Submission of Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Grant of Stock Options under Crescentis Capital Limited (Employee ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Crescentis Capital Limited's Nomination and Remuneration Committee granted 500,000 stock options to Mr. Subba Rao Veera Venkata Meka, Managing Director, under the company's Employees' Stock Option Scheme 2025. The options have an exercise price of Rs. 50 per option. The vesting schedule is split equally at 50% (250,000 options) on May 28, 2027 and 50% on May 28, 2028. Once vested, the options can be exercised within 3 years from the vesting date. The scheme was approved by shareholders on December 26, 2025 and has BSE's in-principle approval to list up to 1,300,000 equity shares arising from exercise of all options under the scheme.
This is a routine corporate governance disclosure regarding ESOP grant to the Managing Director. It aligns management interests with shareholders but does not directly affect shareholder value until options are exercised. No immediate impact on stock price expected from this disclosure.